Notizie AIOM – anno XVII – Pagina 10

15 Novembre 2019

FDA Grants Priority Review to Nivolumab/Ipilimumab in Advanced HCC

November 11, 2019 - The FDA has granted a priority review designation to a supplemental biologics license application for the combination of nivolumab and ipilimumab for the treatment of patients with advanced hepatocellular carcinoma (HCC) who received prior therapy with ...
Leggi tutto

15 Novembre 2019

Regulators’ advice can make a difference for faster patient access to highly innovative therapies

November 12, 2019 - Early dialogue and frequent interactions between medicine developers, regulators, health technology assessment bodies (HTAs) and patients can play a key role in delivering robust data needed to enable accelerated access of patients to highly innovative ...
Leggi tutto

15 Novembre 2019

14 novembre 2019 – Aggiornamento EMA per le aziende sulle impurezze da nitrosammine

15 Novembre 2019

Growing Field of Cardio-Oncology Boosted by Collaboration Between Leading Oncology and Cardiovascular Health Organizations

November 14, 2019 - Providing researchers with access to real-world cancer patient data has the potential to improve care and impact quality of life for cardio-oncology patients everywhere. To accomplish this, two science-based organizations, CancerLinQ LLC, a nonprofit ...
Leggi tutto

15 Novembre 2019

FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma supported by clinical trial results showing high response rate of tumor shrinkage

November 14, 2019 - Today, the U.S. Food and Drug Administration granted accelerated approval to zanubrutinib capsules for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma usually responds ...
Leggi tutto

14 Novembre 2019

14 novembre 2019 – Attivazione web e pubblicazione schede di monitoraggio – Registro Lenvatinib (Eisai)

14 Novembre 2019

Attending community-based lung cancer screening influences smoking behaviour in deprived populations

The impact of lung cancer screening on smoking is unclear, especially in deprived populations who are underrepresented in screening trials. The aim of this observational cohort study was to investigate whether a community-based lung cancer screening programme influenced ...
Leggi tutto

14 Novembre 2019

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Genomes of tumors that are deficient in DNA mismatch repair (dMMR) have high microsatellite instability (MSI-H) and harbor hundreds to thousands of somatic mutations that encode potential neoantigens. Such tumors are therefore likely to be immunogenic, triggering upregulation ...
Leggi tutto

13 Novembre 2019

11 novembre 2019 – Farmaci a base di vitamina D. Informazioni per i medici e “dieci cose da sapere” per tutti

13 Novembre 2019

11 novembre 2019 – Impariamo dall’esperienza per perfezionare il sistema di controllo sui farmaci

LAVORIAMO CON

News

TUMORE AL SENO: METASTASI SI DIFFONDONO COME GOCCE SU UNA SUPERFICIE. LA CAPACITÀ INVASIVA DIPENDE DALLA “FLUIDITÀ” DEL CANCRO

ONE HEALTH FOUNDATION: AL VIA IL PROGETTO IN 36 CENTRI ESTIVI IN ALBANIA. SULLA “NAVE DELLA SALUTE” SVOLTI PIU’ DI 550 TEST E VISITE MEDICHE

AL VIA LA TERZA EDIZIONE DELLA “NAVE DELLA SALUTE” ITALIA-ALBANIA. LA PREVENZIONE SALE A BORDO CON 17 MEDICI SPECIALISTI E 10 AMBULATORI

TOVORAFENIB È LA PRIMA TERAPIA MIRATA APPROVATA IN EUROPA NEL GLIOMA PEDIATRICO DI BASSO GRADO RECIDIVATO O REFRATTARIO, INDIPENDENTEMENTE DAL TIPO DI ALTERAZIONE DI BRAF

TOZORAKIMAB HA SODDISFATTO L’ENDPOINT PRIMARIO DELLO STUDIO DI FASE III MIRANDA NEI PAZIENTI CON BPCO

MIASTENIA GRAVIS, 15MILA PERSONE COLPITE IN ITALIA. “UN’INSTALLAZIONE IMMERSIVA PER COMPRENDERE LA VITA DEI PAZIENTI E AUMENTARE LA CONSAPEVOLEZZA”

MELANOMA, IN ITALIA POSSONO ESSERE “EREDITARI” 2.600 CASI L’ANNO. IMI: “LA PREVENZIONE SIA ANCHE ESAMI GENETICI E SORVEGLIANZA CUTANEA”

Notizie AIOM – anno XVII

FDA Grants Priority Review to Nivolumab/Ipilimumab in Advanced HCC

Regulators’ advice can make a difference for faster patient access to highly innovative therapies

14 novembre 2019 – Aggiornamento EMA per le aziende sulle impurezze da nitrosammine

Growing Field of Cardio-Oncology Boosted by Collaboration Between Leading Oncology and Cardiovascular Health Organizations

FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma supported by clinical trial results showing high response rate of tumor shrinkage

14 novembre 2019 – Attivazione web e pubblicazione schede di monitoraggio – Registro Lenvatinib (Eisai)

Attending community-based lung cancer screening influences smoking behaviour in deprived populations

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

11 novembre 2019 – Farmaci a base di vitamina D. Informazioni per i medici e “dieci cose da sapere” per tutti

11 novembre 2019 – Impariamo dall’esperienza per perfezionare il sistema di controllo sui farmaci